The global spinal fusion market is on track for substantial expansion, with recent projections highlighting a significant surge in its valuation. According to the latest market analysis, the spinal ...
5. Key findings concluded that the use of AMP2, Theradaptive's proprietary adhesive variant of BMP-2, showed healing outcomes equivalent to or better than ICBG. The precise delivery of the protein ...
Theradaptive, a privately held, clinical stage biologics company developing targeted protein therapeutics for spine, orthopedics, soft tissue repair and targeted immuno-oncology, today announced the ...
Pertinent clinical and hematologic data of the patients are presented in Table 1.Ten of the 12 patients were less than eight years of age. A number had a history of serious bacterial infections ...